Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination
Start Learning
Improving the alpha-mannosidosis patient journey
Atogepant for preventive treatment of chronic migraine, PROGRESS phase 3 trial: Richard Lipton, AAN 2023
Dominic Shadbolt: ECTRIMS Patient perspective – Lifestyle interventions as part of a management plan for MS
Stewart Tepper, AAN 2023: Phase 3 ASCEND interim analysis – STS101 for the treatment of acute migraine
Pridopidine: Topline Results from the Phase III Trial, PROOF-HD, for the Treatment of Huntington’s Disease
Rajeev Kumar, MDS 2022: ANX005, a humanized monoclonal antibody for Huntington’s disease, the phase 2 study results
Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy
Wellness in Parkinson’s Disease: A Framework for Management Using a Holistic Culturally Sensitive Approach
Sex, Gender and Sexuality in the Context of Dementia: A Guide to Raise Awareness Amongst Health and Social Care Workers
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Lisa Sarfaty: Exploring and addressing inequities in rare diseases
View
Kristian Steen Frederiksen, EAN 2023: Highlights in Alzheimer’s disease and dementia
View
Barry Singer, ECTRIMS 2022: Diroximel fumarate for relapsing-remitting multiple sclerosis – Phase 3 results from EVOLVE-MS-1
View
Rajeev Kumar, MDS 2022: ANX005, a humanized monoclonal antibody for Huntington’s disease, the phase 2 study results
View
Anthony Béhin, EAN 2023: Safety Profile Overview of Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases
View
Georgina Arrambide, ECTRIMS 2022: Serum neurofilament light chain (sNfL) Z score cut-offs in multiple sclerosis
View
Blood-based biomarkers: Supporting the diagnosis and treatment of Alzheimer’s disease
View
Dominic Shadbolt: ECTRIMS Patient perspective – Technologies and tools to predict patient outcomes in MS
View
Sabrina Sacconi, EAN 2023: The MycarinG study – rozanolixizumab in the treatment of muscle-specific kinase autoantibody-positive myasthenia gravis
View
Luca Leonardi, EAN 2023: Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis
View